The Dixie Group (DXYN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
26 Mar, 2026Executive summary
Annual Meeting scheduled for May 6, 2026, to elect six directors, hold a say-on-pay vote, and ratify the external auditor for 2026.
Shareholders of record as of March 6, 2026, are eligible to vote; Common Stock has one vote per share, Class B Common Stock has 20 votes per share.
Board recommends voting in favor of all proposals, including director nominees, executive compensation, and auditor ratification.
Voting matters and shareholder proposals
Proposals include election of six directors, advisory vote on executive compensation, and ratification of Forvis Mazars, LLP as independent auditor.
Shareholder proposals for the 2027 meeting must be received by November 4, 2026, for inclusion in proxy materials.
Abstentions and broker non-votes do not affect the outcome of director elections or say-on-pay.
Board of directors and corporate governance
Board consists of six nominees with diverse backgrounds in finance, operations, academia, and environmental compliance.
Four directors are independent per SEC and NASDAQ standards; independent directors meet in executive session quarterly.
Board committees include Executive, Audit, and Compensation/Nominations and Corporate Governance Committees.
Board reviews management succession plans and emphasizes continuity and experience in director selection.
Latest events from The Dixie Group
- Improved margins and reduced losses amid industry headwinds and tariff challenges.DXYN
Q4 202526 Mar 2026 - Profitability returned in Q2 2024 as cost savings and efficiencies offset weak sales.DXYN
Q2 20242 Feb 2026 - Q3 sales and margins declined, losses widened, and cost cuts target recovery as housing rebounds.DXYN
Q3 202417 Jan 2026 - 2025 meeting covers director elections, say-on-pay, and auditor ratification, with strong board oversight.DXYN
Proxy Filing2 Dec 2025 - Net loss widened to $13M in 2024 as sales fell and cost actions intensified amid industry headwinds.DXYN
Q4 202424 Nov 2025 - Q2 2025 saw higher net income and margins despite lower sales, with ongoing liquidity risks.DXYN
Q2 202523 Nov 2025 - Gross margin rose to 26.8% as net loss narrowed, but market and liquidity risks persist.DXYN
Q1 202521 Nov 2025 - Q3 2025 sales declined, but cost controls and a profit plan aim to drive future recovery.DXYN
Q3 202517 Nov 2025